# Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer

> **NCT06931873** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Changhai Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **COMBINATION_PRODUCT:** SCRT+Capoex+QL706
- **COMBINATION_PRODUCT:** LCRT+Capoex+QL706

## Key facts

- **NCT ID:** NCT06931873
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2028-03-01
- **Final completion:** 2035-03-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06931873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06931873, "Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06931873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*